METHOD TO PRODUCE AN AEROSOL

Abstract: The invention relates to a method of converting a medicament to a form which can be used for administration to the airways or respiratory tracts of a mammal, wherein a liquid which consists in or includes a medicament is transformed to an aerosol which includes small liquid particles, with the aid of a gas stream or with the aid of other means, and wherein the liquid particles are collected in the gas stream or in a gas stream respectively, and wherein the liquid particles are collected in a gas which contains helium and/or neon and preferably also oxygen. The invention also relates to the use of a helium-containing and/or neon-containing gas mixture for producing an aerosol and a medicament preparation in the form of an aerosol consisting in liquid particles which are comprised of or include a medicament, and a gas mixture that contains helium and/or neon.

Description: Method to Produce an Aerosol DESCRIPTION The present invention relates to a method of bringing a medicament into a form in which it can be inhaled, there being obtained an aerosol which when inhaled penetrates further down into the airways and results in more effective use of the medicament. In the case of respiratory tract infections, such as asthma and chronic bronchitis, it is highly beneficial to be able to deliver a medicament via inhalation, both with respect to maintenance treatment and in respect to acute deterioration of the illness. The medicament is conveniently administered with the aid of a nebulizer, which is normally driven with compressed air or with pure oxygen gas. One problem experienced in inhalation treatment processes is that of being able to administer the medicament to the location where it will do most good. When using traditional nebulizing equipment, a large part of the adminis¬ tered dosage will land up in the oral cavity and pharynx and only a small part of the dosage will arrive in the bronchial tree. A highly effective nebulizer has recently been described in EP-B1-0191018. Improved peripheral deposition of the nebulized medicament is obtained with this nebulizer, and therewith a better effect, less risk of side effects, lower medicament consumption and shorter treatment times. Studies made on people suffering from mild to moderate asthma have shown that these deposit inhaled particles more centrally in the bronchial tree than do healthy people. This may be due to a stronger tendency towards turbulence in the airways of asthmatics, for instance, which may, in turn, be because the airways of such people are narrow or partially blocked, as in the case with cystic fibrosis, for instance. An object of the present invention is to improve further the peripheral deposition of medicaments administered to the airways or respiratory tracks of a patient and therewith reduce the necessary effective medicament dosage, or to shorten the necessary treatment time, or a combination of these benefits. From a medical aspect, it is important that the effect of treatment is achieved rapidly. CORRE More effective deposition and lower local medicament dosages also reduce the risk of side effects. Another object of the invention is to provide a medicament preparation in the form of an aerosol which consists in liquid particles that are comprised of or include a medicament and a gas mixture which is able to transport the medica¬ ment-containing liquid further down into the airways or respiratory tracts of a patient than those gas flows hitherto used. Still a further object of the invention is to provide the use of a gas mixture for producing an aerosol, said aerosol being comprised of liquid particles which include medicaments, and a carrier gas flow which is able to transport the medicament-containing liquid further down into the airways, to the alveoli than hitherto used gas flows. According to the present invention, the peripheral deposition of medica¬ ments delivered to the airways or respiratory tracts is improved when the medicament is a liquid or is dissolved or dispersed in a liquid, the liquid is converted to liquid particles and collected in a carrier gas which contains helium and/or neon. The carrier gas is preferably a mixture of helium and/or neon and oxygen, particularly helium and oxygen. The helium and/or neon concentration will advantageously constitute at least 70 percent by volume of the carrier gas. The liquid used will be compatible with the airways, and may be water for instance. Advantageous embodiments of the invention will be apparent from the depending Claims. The advantage of using helium and/or neon as a carrier gas for liquid particles which consist in or include a medicament is that at normal pressure and temperatures helium in particular, but also neon, has a lower density and viscosity than other gaseous substances, for instance air. This property is utilized for passing a medicament further down into the finest airways, the alveoli, with lower turbulence. The present invention will now be described in more detail with reference to the accompanying drawing, in which Fig. 1 is a schematic cross-sectional view of a nebulizer in which liquid particles are produced with the aid of a gas stream; and Fig. 2 is a schematic cross-sectional view of a nebulizer in which liquid particles are produced ultrasonically. Fig. 1 illustrates a nebulizer 1 which includes a container 2 containing a liquid 3. The liquid may be a medicament or may consist in a medicament solution or a medicament dispersion, for instance a medicament against asthma. The nebulizer 1 also includes two mutually spaced and mutually parallel discs 4, 5, of which the bottom disc 5 is connected with the liquid 3 through a conduit 7. The conduit 7 terminates in a small opening 10 in the upper surface of the disc 5. The conduit 7 is connected with a propellant gas conduit immediately beneath the opening 10. This propellant gas conduit is connected to a gas source, normally air or oxygen. The nebulizer also includes an outlet 9 for the aerosol produced. The medicament-containing liquid 3 is present in the container 2 when taking the nebulizer 1 into use. The propellant gas is caused to flow through the conduit 8 to the conduit 7 and thereafter through the opening 10. The gas therewith draws liquid 3 from the container 2 by suction, this liquid accompany¬ ing the gas flow onto the upper disc 4, where the liquid is spread radially and forms small liquid droplets at the disc edges, these liquid droplets being trans¬ ported towards the outlet 9 by the gas flow. Fig. 2 illustrates a nebulizer 20 in which liquid droplets are produced ultrasonically. The nebulizer includes a container 12 which contains a liquid 13 in which a medicament is dissolved or dispersed. An ultrasound source 11 is mounted beneath the container 12. A gas conduit 18 connected to a source of gas under pressure opens out into an outlet 9. The gas used is normally air or oxygen. The container 12 is filled with liquid when using the nebulizer 20. The ultrasound source is connected to an energy source in a manner not shown, to produce small liquid particles across the surface of the liquid. The gas flowing through the conduit 18 entrains these liquid particles through the outlet opening 9. According to another embodiment of the nebulizer similar to the Fig. 1 embodiment, the upper disc 3 is replaced with a rapidly rotating disc. The liquid leaving the opening in the bottom disc impinges on the rotating disc and is divided thereby into small particles. In accordance with the invention, there is used for producing the present medicament-containing aerosol a gas or a gas mixture whose components have a low molecular weight. The gas is characterized by containing helium and/or neon. The gas will also conveniently contain oxygen, in addition to helium and/or neon. The preferred light gas is helium. The oxygen content should not be less than 15 percent by weight, and is conveniently about 20 percent or higher. In a preferred embodiment, the helium and/or neon content is at lowest 70 percent by volume. Suitable medicaments for conversion to an aerosol form are, for instance, BRICANYL and ADRENALIN marketed by Draco; VENTOLINE and BECOTIDE marketed by Glaxo; and, LOMUDAL marketed by Fisons.

Claims: CLAIMS 1. A method of converting a medicament to a form usable for administration of the medicament to the airways or respiratory tracts of mammals, wherein a liquid which consists in or includes a medicament is transformed to an aerosol which contains small liquid particles with the aid of a gas stream or with the aid of other means, and wherein the liquid particles are collected in the gas stream or in a gas stream respectively, characterized by collecting the liquid particles in a helium-containing and/or a neon-containing gas. 2. A method according to Claim 1 , characterized in that the gas is a mixture of helium and/or neon and oxygen. 3. A method according to Claim 1 or Claim 2, characterized in that the gas contains at lowest 70 percent by volume helium and/or neon. 4. ' The use of a helium-containing and/or neon-containing gas mixture to produce an aerosol which includes liquid particles that consist in or include medicament, and a carrier gas. 5. The use according to Claim 4, characterized in.that the liquid particles are produced with the aid of the carrier gas. 6. The use according to Claim 4 or Claim 5, characterized in that the gas is a mixture that contains helium and/or neon and oxygen. 7. The use according to Claim 6, characterized in that the helium-content and/or the neon-content of the gas is at lowest 70 percent by volume. 8. A medicament preparation in the form of an aerosol, characterized in that the aerosol is comprised of liquid particles which consist in or include medicament, and a gas mixture containing helium and/or neon. 9. A preparation according to Claim 8, characterized in that the gas mixture is a mixture containing helium and/or neon and oxygen. 10. A preparation according to Claim 8 or Claim 9, characterized in that the gas mixture contains at lowest 70 percent by volume helium and/or neon.

Inventors: HAMMARLUND NILS, HAMMARLUND, NILS
Applicants: AGA AB, HAMMARLUND NILS, AGA AKTIEBOLAG, HAMMARLUND, NILS
Application year: 1995
Main classification: A61M11
IPC codes: A61M11